Department of Cardiology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Donato, San Donato Milanese, Milan, Italy.
Department of Cardiology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Donato, San Donato Milanese, Milan, Italy.
Am J Cardiol. 2023 Aug 1;200:178-187. doi: 10.1016/j.amjcard.2023.05.045. Epub 2023 Jun 16.
Despite the growing experience with MitraClip in the broad spectrum of mitral regurgitation (MR), limited data are available regarding the independent prognostic role on survival of different mitral regurgitation etiology subtypes. We sought to evaluate the impact of flail leaflet etiology in a large series of patients with primary MR (PMR) who underwent MitraClip treatment. The study included 588 patients with significant PMR from the multicenter GIOTTO (Italian Society of Interventional Cardiology [GIse] registry Of Transcatheter treatment of mitral valve regurgitaTiOn), stratified into 2 groups according to MR etiology: flail (n = 300) and flail (n = 288). The primary end point was a composite of cardiac death and first rehospitalization for heart failure (HF). To account for the baseline differences, patients were propensity score-matched 1:1. Flail leaflet etiology was present in about a half of the patients. Acute technical success was achieved in 98% of the overall cohort, with no significant differences between the study groups (p = 0.789). At the 2-year Kaplan-Meier analysis, the primary end point occurred in 13% of flail patients compared with 23% in flail (p = 0.009). The flail group presented lower rates of both cardiac death and rehospitalization for HF, whereas a similar overall death rate was observed between the groups. A multivariate Cox regression analysis identified flail leaflet etiology as an independent predictor of favorable outcome in terms of the primary end point (hazard ratio 0.141, 95% confidence interval 0.049 to 0.401, p <0.001). After propensity score matching, flail patients had confirmed lower rates of cardiac mortality and rehospitalization for HF but similar rates of overall death. In conclusion, flail leaflet-related etiology was common in patients with PMR who underwent MitraClip treatment and was an independent predictor of midterm favorable clinical outcomes.
尽管在广泛的二尖瓣反流(MR)范围内积累了越来越多的 MitraClip 经验,但关于不同二尖瓣反流病因亚型对生存的独立预后作用的数据有限。我们试图评估在接受 MitraClip 治疗的大量原发性 MR(PMR)患者中,连枷瓣病因的影响。该研究纳入了来自多中心 GIOTTO(意大利介入心脏病学会[GIse]经导管治疗二尖瓣反流注册研究)的 588 例有症状的 PMR 患者,根据 MR 病因分为 2 组:连枷(n=300)和连枷(n=288)。主要终点是心脏死亡和心力衰竭(HF)首次再住院的复合终点。为了考虑到基线差异,患者按 1:1 进行倾向评分匹配。约一半的患者存在连枷瓣病因。整体队列的急性技术成功率达到 98%,两组间无显著差异(p=0.789)。在 2 年的 Kaplan-Meier 分析中,连枷组患者的主要终点发生率为 13%,而连枷组为 23%(p=0.009)。连枷组的心脏死亡和 HF 再住院率均较低,而两组的总死亡率相似。多变量 Cox 回归分析确定连枷瓣病因是主要终点(危险比 0.141,95%置信区间 0.049 至 0.401,p<0.001)良好预后的独立预测因素。在倾向评分匹配后,连枷患者的心脏死亡率和 HF 再住院率较低,但总死亡率相似。总之,连枷瓣相关病因在接受 MitraClip 治疗的 PMR 患者中很常见,是中期良好临床结局的独立预测因素。